Susquehanna International Group, LLP Pacira Bio Sciences, Inc. Transaction History
Susquehanna International Group, LLP
- $641 Billion
- Q4 2024
A detailed history of Susquehanna International Group, LLP transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 186,420 shares of PCRX stock, worth $4.95 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
186,420
Previous 12,093
1441.55%
Holding current value
$4.95 Million
Previous $182,000
1829.67%
% of portfolio
0.0%
Previous 0.0%
Shares
25 transactions
Others Institutions Holding PCRX
# of Institutions
253Shares Held
46.5MCall Options Held
436KPut Options Held
369K-
Black Rock Inc. New York, NY8.01MShares$212 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.26MShares$140 Million0.0% of portfolio
-
Pacer Advisors, Inc. Malvern, PA3.26MShares$86.6 Million0.15% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.99MShares$52.9 Million0.06% of portfolio
-
State Street Corp Boston, MA1.97MShares$52.1 Million0.0% of portfolio
About Pacira BioSciences, Inc.
- Ticker PCRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 45,824,200
- Market Cap $1.22B
- Description
- Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...